Mrs. Gina Yarbrough, PT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 322 Meandering Ln, Turlock, CA 95382 Phone: 209-404-3835 |
Dr. Drew D Lewis, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1739 Colorado Ave, Turlock, CA 95382 Phone: 209-448-3000 Fax: 209-442-4116 |
Ms. Erin Hannink, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3800 Geer Rd Suite 101, Turlock, CA 95382 Phone: 209-667-1729 Fax: 209-667-1799 |
Laura Mcintosh-sapien, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 875 E Canal Dr Ste 1, Turlock, CA 95380 Phone: 209-633-3077 Fax: 209-633-3078 |
David Andrew Lindenberg, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1739 Colorado Ave, Turlock, CA 95382 Phone: 209-448-3000 Fax: 209-442-4116 |
News Archive
Most patients who undergo total knee replacement are age 60 to 80. More than 90 percent of these individuals experience a dramatic reduction in knee pain and a significant improvement in the ability to perform common activities. However questions have been raised about the decline in physical function over the long term despite the absence of implant-related problems.
In a paper published in the journal Pain, Saint Louis University researcher Daniela Salvemini, Ph.D., reports discovering a key molecular pathway that drives cancer-related bone pain while providing a potential solution with a drug that already is on the market.
Royal Philips Electronics today introduced the Philips Panorama High Field Open (HFO) Oncology Configuration for radiation therapy, a magnetic resonance (MR) imaging solution for dedicated oncology use, at this year's American Society for Therapeutic Radiology and Oncology (ASTRO) in San Diego, CA.
Before bite-sized crustaceans like crayfish, shrimp and prawns land on our dinner plates, they first have to get fat themselves - and it turns out they relish the freshwater snails that transmit the parasite that causes schistosomiasis, the second most devastating parasitic disease worldwide, after malaria.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
› Verified 4 days ago